TY - JOUR
T1 - Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis
AU - Snir, Omri
AU - Gomez-Cabrero, David
AU - Montes, Ariana
AU - Perez-Pampin, Eva
AU - Gómez-Reino, Juan J.
AU - Seddighzadeh, Maria
AU - Klich, Katharina U.
AU - Israelsson, Lena
AU - Ding, Bo
AU - Catrina, Anca I.
AU - Holmdahl, Rikard
AU - Alfredsson, Lars
AU - Klareskog, Lars
AU - Tegnér, Jesper
AU - Gonzalez, Antonio
AU - Malmström, Vivianne
AU - Padyukov, Leonid
N1 - Generated from Scopus record by KAUST IRTS on 2021-02-16
PY - 2014/8/20
Y1 - 2014/8/20
N2 - Introduction: Genetic susceptibility to complex diseases has been intensively studied during the last decade, yet only signals with small effect have been found leaving open the possibility that subgroups within complex traits show stronger association signals. In rheumatoid arthritis (RA), autoantibody production serves as a helpful discriminator in genetic studies and today anti-citrullinated cyclic peptide (anti-CCP) antibody positivity is employed for diagnosis of disease. The HLA-DRB1 locus is known as the most important genetic contributor for the risk of RA, but is not sufficient to drive autoimmunity and additional genetic and environmental factors are involved. Hence, we addressed the association of previously discovered RA loci with disease-specific autoantibody responses in RA patients stratified by HLA-DRB1*04.Methods: We investigated 2178 patients from three RA cohorts from Sweden and Spain for 41 genetic variants and four autoantibodies, including the generic anti-CCP as well as specific responses towards citrullinated peptides from vimentin, alpha-enolase and type II collagen.Results: Our data demonstrated different genetic associations of autoantibody-positive disease subgroups in relation to the presence of DRB1*04. Two specific subgroups of autoantibody-positive RA were identified. The SNP in PTPN22 was associated with presence of anti-citrullinated enolase peptide antibodies in carriers of HLA-DRB1*04 (Cochran-Mantel-Haenszel test P = 0.0001, P corrected
AB - Introduction: Genetic susceptibility to complex diseases has been intensively studied during the last decade, yet only signals with small effect have been found leaving open the possibility that subgroups within complex traits show stronger association signals. In rheumatoid arthritis (RA), autoantibody production serves as a helpful discriminator in genetic studies and today anti-citrullinated cyclic peptide (anti-CCP) antibody positivity is employed for diagnosis of disease. The HLA-DRB1 locus is known as the most important genetic contributor for the risk of RA, but is not sufficient to drive autoimmunity and additional genetic and environmental factors are involved. Hence, we addressed the association of previously discovered RA loci with disease-specific autoantibody responses in RA patients stratified by HLA-DRB1*04.Methods: We investigated 2178 patients from three RA cohorts from Sweden and Spain for 41 genetic variants and four autoantibodies, including the generic anti-CCP as well as specific responses towards citrullinated peptides from vimentin, alpha-enolase and type II collagen.Results: Our data demonstrated different genetic associations of autoantibody-positive disease subgroups in relation to the presence of DRB1*04. Two specific subgroups of autoantibody-positive RA were identified. The SNP in PTPN22 was associated with presence of anti-citrullinated enolase peptide antibodies in carriers of HLA-DRB1*04 (Cochran-Mantel-Haenszel test P = 0.0001, P corrected
UR - http://arthritis-research.biomedcentral.com/articles/10.1186/s13075-014-0414-3
UR - http://www.scopus.com/inward/record.url?scp=84908084440&partnerID=8YFLogxK
U2 - 10.1186/s13075-014-0414-3
DO - 10.1186/s13075-014-0414-3
M3 - Article
C2 - 25138370
SN - 1478-6362
VL - 16
JO - Arthritis Research and Therapy
JF - Arthritis Research and Therapy
IS - 4
ER -